57.58 USD
↘ 0.36 (0.62%)AT CLOSE (11:59 AM EDT)
Bristol-Myers Squibb Co.
BMYNYSE • USD
57.53
↘ 0.06 (0.10%)
POST MARKET (AS OF 08:02 PM EDT)
Post Market
AS OF 08:02 PM EDT
57.53
↘ 0.06 (0.10%)
Market: CLOSED
Bristol-Myers Squibb Co. (BMY) trades at $57.58 per share. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Key drivers include exceptional Return on Equity (36.3%), a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation side, BMY appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Jul 10, 2026.
Open?$57.79
High?$57.94
Low?$56.94
Prev. Close?$57.94
Volume?11.2M
Avg. Volume?13.4M
VWAP?$57.42
Rel. Volume?0.84x
Bid / Ask
Bid?$57.35 × 600
Ask?$57.55 × 200
Spread?$0.20
Midpoint?$57.45
Valuation & Ratios
Market Cap?117.6B
Shares Out?2.0B
Float?2.0B
Float %?99.9%
P/E Ratio?16.16
P/B Ratio?5.86
EPS?$3.56
Dividend?4.31%
Ex-Dividend?N/A
News
Profile
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Themes
Address
ROUTE 206 AND PROVINCE LINE ROAD
PRINCETON, NJ 08543
Phone: (609) 252-4621
PRINCETON, NJ 08543
Phone: (609) 252-4621
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?50
Momentum?35
Short Sent.?64
Piotroski F-Score?6/9Mixed
Altman Z-Score?2.41Grey
Confidence?73%Moderate
Short InterestLow
Short % of Float?1.99%Low
Short Interest?40.5M
Days to Cover?2.5
Free Float2.0B
Avg Daily Volume16.4M
Settlement Date2026-06-30
Financial Health
Current Ratio?1.42Adequate
Quick Ratio?1.28Adequate
Cash Ratio?0.50Adequate
Debt/Equity?2.22High
ValuationATTRACTIVELY VALUEDvs 10 peers + S&P 500
Score89/100
P/E?16.2CHEAP▾
Peers100
S&P77
P/B?5.86FAIR▾
Peers90
S&P31
P/S?2.43CHEAP▾
Peers91
S&P58
P/FCF?9.9CHEAP▾
Peers100
S&P89
EV/EBITDA?11.3CHEAP▾
Peers91
S&P73
EV/Sales?3.14FAIR▾
Peers100
S&P59
Returns & Efficiency
ROE?36.3%STRONG▾
Peers60
S&P84
ROA?8.4%STRONG▾
Peers45
S&P68
Cash Flow & Enterprise
FCF?$11.9B
Enterprise Value?$152.5B
Fundamentals ratios updated end of day